Results 111 to 120 of about 487,050 (179)

Codon deoptimization of multispecific biologics reduces mispairing during transient mammalian protein expression. [PDF]

Front Bioeng Biotechnol
Chang TZ, Ma W, Guo J, Hu J, Mix K, Tang Y, Wong K, Bric-Furlong E, Lennon A, Hall B, Hoffmann D.   +10 more
europepmc   +1 more source

Single-Chain Variable Fragment Fusion Proteins for Targeted Delivery and Therapy. [PDF]

Pharmaceuticals (Basel)
Yang L, Yin Y, Liu X, Guo B.
europepmc   +1 more source

A Festschrift Celebrating Dr. Dimiter Stanchev Dimitrov: Antibodies, Innovation, and Impact on Infectious Disease and Cancer Research. [PDF]

Antibodies (Basel)
Prabakaran P, Ying T, Li W.
europepmc   +1 more source

Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry. [PDF]

MAbs
Hecht E, Martin E, Liko I, Mahan A, Sahasrabuddhe A, Tajoddin NN, Campuzano IDG.   +6 more
europepmc   +1 more source

Camelid VHHs as a Versatile Platform for Combating Viral Infections. [PDF]

Pharmaceuticals (Basel)
Mufrrih M, Alandijany TA.
europepmc   +1 more source

B cells enable autoreactive T cells to avoid suppression. [PDF]

Proc Natl Acad Sci U S A
Funsten M, de Pooter R, Varanasi V, Burrows M, Block K, Kuznetsov A, Serreze D, Huang H, Chervonsky A.   +8 more
europepmc   +1 more source

Editorial: Bispecific antibodies and their conjugates in solid tumors and hematological malignancies. [PDF]

Front Immunol
Püsküllüoğlu M, Pacholczak-Madej R.
europepmc   +1 more source

Pharmacological considerations for next-generation protein therapeutics in cardiovascular disease. [PDF]

J Pharmacol Exp Ther
Lin E, Momin N.
europepmc   +1 more source

Immunotherapy for Cancer: Current Advances and Future Directions. [PDF]

Int J Mol Sci
Saxena T, Zaman S, Dhanda H, Swain SK, Kushwaha N, Kaur M, Kamal R, Zaheer S, Tanwar P, Kumar N, Siraj F, Rishi B, Misra A.   +12 more
europepmc   +1 more source

A comprehensive evaluation of the human Tg32 and Tg276 FcRn transgenic mouse and non-human primate models for predicting antibody pharmacokinetics in human. [PDF]

MAbs
Gajewska M, Kiffe M, Calonder C, Engelhardt V, Pou I Miralbell C, Gonzalo-Gil E, Christianson G, Bethur N, Flora A.   +8 more
europepmc   +1 more source